首页> 外文期刊>Chinese Journal of Contemporary Neurology and Neurosurgery >Investigation of pathogenetic mechanism, prevention and treatment of Alzheimer's disease via systemic approaches
【24h】

Investigation of pathogenetic mechanism, prevention and treatment of Alzheimer's disease via systemic approaches

机译:通过系统途径研究阿尔茨海默氏病的发病机理,预防和治疗

获取原文
       

摘要

Alzheimer's disease (AD) becomes a major disease affecting the elderly with high prevalence. However, no disease-modifying therapies are currently available. AD has long been regarded as a disease of brain itself, but recent studies found that systemic disorders are associated with risk for AD. During the period of Twelfth Five-Year Plan for National Economic and Social Development, our team tried to reveal the pathogenesis, targets, amyloid β-protein (Aβ) clearence pathway and drugs from both central and peripheral approaches, and have discovered: 1) the ratio of p75 neurotrophin receptor (p75NTR) in the brain of AD regulates the over?production and clearence of Aβ in sporadic AD. 2) Peripheral Aβ is able to enter brain, forms AD-type pathologies and induces neuronal deficits, revealing the peripheral mechanism of AD. 3) The effectiveness and safety of brain A β clearance by peripheral organs and tissues has been verified. Based on these findings, we proposed a systemic view of AD, to understand pathogenesis and develop novel diagnostic methods and therapies from a systemic approach.?DOI: 10.3969/j.issn.1672-6731.2018.01.004.
机译:阿尔茨海默氏病(AD)成为影响老年人的主要疾病,发病率很高。但是,目前尚无可改善疾病的疗法。长期以来,AD一直被认为是一种大脑疾病,但是最近的研究发现,全身性疾病与AD风险有关。在《国民经济和社会发展第十二个五年规划》期间,我们的团队试图揭示中枢和外周途径的发病机制,靶标,淀粉样β蛋白(Aβ)清除途径和药物,并发现:1) AD大脑中p75神经营养因子受体(p75NTR)的比例调节散发性AD中Aβ的过量生成和清除。 2)外周血Aβ能够进入大脑,形成AD型病理并诱发神经元缺陷,揭示了AD的外周机制。 3)验证了大脑通过外围器官和组织清除Aβ的有效性和安全性。基于这些发现,我们提出了AD的系统性观点,以了解发病机理并通过系统性方法开发新的诊断方法和疗法。DOI:10.3969 / j.issn.1672-6731.2018.01.004。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号